✦ LIBER ✦

Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay

✍ Scribed by Rita S. Mehta; Richard Bornstein; Ing-Ru Yu; Ricardo J. Parker; Christine E. McLaren; Khanh P. Nguyen; Kuo-Tung Li; John P. Fruehauf

Book ID: 110292377
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 181 KB
Volume: 66
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1010604502627

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extreme drug resistance assay does not i

Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer

✍ Robert W. Holloway 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Extreme drug resistance assay does not i

Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer

✍ Amer K. Karam; Beth Y. Karlan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Factors Associated With Success of the E

Factors Associated With Success of the Extreme Drug Resistance Assay in Primary Breast Cancer Specimens

✍ Robert J. Ellis; Carol J. Fabian; Bruce F. Kimler; Ossama Tawfik; Matthew S. May 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 83 KB

Extreme drug resistance assay results do

Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer

✍ Amer K. Karam; Jing Wang Chiang; Ewina Fung; Vladimir Nossov; Beth Y. Karlan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 167 KB

In vitro assays for the evaluation of dr

In vitro assays for the evaluation of drug resistance in tumor cells

✍ Jozef Hatok; Eva Babusikova; Tatiana Matakova; Dusan Mistuna; Dusan Dobrota; Pet 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

Extreme drug resistance assay and respon

Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma

✍ Eltabbakh, Gamal H. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Background and Objectives: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer (EOC) has recently been